
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $300K | -- | -- | -$0.34 | -- |
08/05/2025 | Q2 | $16.9M | -- | -- | -$0.35 | -- |
05/13/2025 | Q1 | $22.2M | $18M | -$14.58 | -$0.36 | -$14.22 |
02/12/2025 | Q4 | $10.4M | $16.9M | -$1.20 | -$0.93 | -$0.27 |
12/02/2024 | Q3 | -- | $935K | -$2.38 | -- | -- |
08/05/2024 | Q2 | $17.8M | $13.6M | -$0.27 | -$0.26 | -$0.01 |
05/06/2024 | Q1 | $40.6M | $18.1M | -$2.07 | -$0.14 | -$1.93 |
02/07/2024 | Q4 | $11.5M | $14M | $5.64 | -$0.28 | $5.92 |
12/06/2023 | Q3 | $700K | $680K | $0.12 | -$0.34 | $0.46 |
08/03/2023 | Q2 | $15.5M | $7.3M | $1.56 | $0.08 | $1.48 |
05/04/2023 | Q1 | -- | $21.3M | -$1.02 | -- | -- |
02/06/2023 | Q4 | -- | $10.6M | -$0.41 | -- | -- |
12/13/2022 | Q3 | -- | $1M | -$2.79 | -- | -- |
08/03/2022 | Q2 | -- | $25.9M | $0.36 | -- | -- |
05/09/2022 | Q1 | -- | $49.6M | $2.74 | -- | -- |
02/03/2022 | Q4 | -- | $15.3M | $1.34 | -- | -- |
12/07/2021 | Q3 | -- | $4M | -$0.13 | -- | -- |
08/05/2021 | Q2 | -- | $34.9M | $3.61 | -- | -- |
05/05/2021 | Q1 | -- | $55.9M | $0.65 | -- | -- |
02/04/2021 | Q4 | -- | $13.7M | $0.51 | -- | -- |
12/08/2020 | Q3 | -- | $4.9M | $2.30 | -- | -- |
08/06/2020 | Q2 | -- | $26.1M | $0.28 | -- | -- |
05/11/2020 | Q1 | -- | $50.5M | $0.48 | -- | -- |
02/06/2020 | Q4 | -- | $11M | $0.11 | -- | -- |
12/05/2019 | Q3 | -- | $1.4M | $2.20 | -- | -- |
08/06/2019 | Q2 | -- | $57.6M | $2.17 | -- | -- |
05/07/2019 | Q1 | -- | $48.5M | $1.01 | -- | -- |
02/11/2019 | Q4 | -- | $14.8M | -$0.33 | -- | -- |
12/06/2018 | Q3 | -- | $1.6M | $0.09 | -- | -- |
08/06/2018 | Q2 | -- | $26.5M | $1.09 | -- | -- |
05/07/2018 | Q1 | -- | $35.6M | -$0.67 | -- | -- |
02/06/2018 | Q4 | -- | $17.5M | $1.05 | -- | -- |
12/11/2017 | Q3 | -- | $4.7M | -$2.29 | -- | -- |
08/07/2017 | Q2 | -- | $51.5M | $0.66 | -- | -- |
05/08/2017 | Q1 | -- | $56.2M | $0.70 | -- | -- |
02/06/2017 | Q4 | -- | $17.4M | -$0.21 | -- | -- |
12/02/2016 | Q3 | -- | $4.9M | -$0.41 | -- | -- |
08/04/2016 | Q2 | -- | $46.9M | $0.56 | -- | -- |
05/05/2016 | Q1 | -- | $71.9M | $1.05 | -- | -- |
02/08/2016 | Q4 | -- | $20.6M | -$0.36 | -- | -- |
12/15/2015 | Q3 | -- | $2.4M | -$0.70 | -- | -- |
Alico reported $18M worth of top line sales in its most recent quarter.
Alico announced earnings per share of -$14.58 which represents a miss of analyst forecast a -$0.36 per share.
Alico reported -$149.7M that represents -$19.60 per share over the last quarter.
Alico's earnings are forecast to grow from $0.91 per share to -$5.60 per share next year representing an increase of --.
Alico's next earnings date is August 5, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.